ProCE Banner Activity

Overview of Biomarker-Selected Immune Checkpoint Blockade in Lung Cancer

Slideset Download
Download this slideset from Jamie E. Chaft, MD to see a summary of key data on the use of immune checkpoint inhibitor therapy for patients with lung cancer, with information on when IO biomarkers are needed to select optimal therapy.

Released: July 09, 2020

Expiration: July 08, 2021

No longer available for credit.

Share

Faculty

Jamie E. Chaft

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York